- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02943811
Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer
Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer: a Multi-centric Study
Study Overview
Detailed Description
The investigators retrospectively collected data regarding patients who received operation by laparoscopy for presumed clinical stage I endometrial cancer. The subjects were then stratified according to the use or not of the uterine manipulator. The investigators also considered the actual type of manipulator used. Then disease-free, disease-specific and overall survival were evaluated, as well as all the possible factors associated with prognosis.
Data were retrieved from specifically designed research quality internal surgical databases, prospectively updated by trained residents on a regular basis, in order to capture all the possible surgical and follow-up data.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical stage I endometrial cancer
- Laparoscopic operation
Exclusion Criteria:
- post-operative oncologic follow-up < 12 months
- extra-uterine evidence of disease
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy with the use of a uterine manipulator
|
Patients were operated laparoscopically with the aid or not of an intrauterine probe to manipulate the uterus
|
NO MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy without the use of a uterine manipulator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disease recurrence
Time Frame: 4 years
|
Relapse of disease during follow-up
|
4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
disease specific survival
Time Frame: 4 years
|
Kaplan Meyer curves and Log-rank test to explore disease-specific survival
|
4 years
|
overall survival
Time Frame: 4 years
|
Kaplan Meyer curves and Log-rank test to explore overall survival
|
4 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stefano Uccella, Università degli Studi dell'Insubria
Publications and helpful links
General Publications
- Marcos-Sanmartin J, Lopez Fernandez JA, Sanchez-Paya J, Pinero-Sanchez OC, Roman-Sanchez MJ, Quijada-Cazorla MA, Candela-Hidalgo MA, Martinez-Escoriza JC. Does the Type of Surgical Approach and the Use of Uterine Manipulators Influence the Disease-Free Survival and Recurrence Rates in Early-Stage Endometrial Cancer? Int J Gynecol Cancer. 2016 Nov;26(9):1722-1726. doi: 10.1097/IGC.0000000000000808.
- Tinelli R, Cicinelli E, Tinelli A, Bettocchi S, Angioni S, Litta P. Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature. Surg Oncol. 2016 Jun;25(2):98-103. doi: 10.1016/j.suronc.2016.03.005. Epub 2016 Mar 23.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 521
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrial Cancer
-
Assistance Publique - Hôpitaux de ParisUniversité Montpellier; Ecole d'econmie de Paris (PSE)-Hospinnomics; Université...CompletedEndometrial Cancer Stage I | Endometrial Cancer Stage IIFrance
-
Radboud University Medical CenterMaastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaboratorsRecruitingEndometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IVNetherlands
-
Batman Training and Research HospitalEskisehir Osmangazi UniversityCompletedGynecologic Cancer | Endometrial Cancer Stage
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Endometrial CancerChina
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Samsung Medical CenterRecruitingEndometrial Cancer Stage IKorea, Republic of
-
Duke UniversityDuke Cancer InstituteCompleted
-
Far Eastern Memorial HospitalCompletedOutcome of Endometrial CancerTaiwan
-
Rambam Health Care CampusCompletedSerous Papillary Endometrial CancerIsrael
-
Masonic Cancer Center, University of MinnesotaCompletedCervical Cancer | Ovarian Cancer | Uterine Endometrial CancerUnited States
Clinical Trials on UTERINE MANIPULATOR
-
Catholic University of the Sacred HeartUnknown
-
Universita di VeronaRecruitingEndometrial NeoplasmsItaly
-
Memorial Sloan Kettering Cancer CenterCompletedGynecologic Condition | Scheduled for a Total Laparoscopic or Robotic-assisted HysterectomyUnited States
-
Ain Shams Maternity HospitalCompleted
-
Instituto de Investigacion Sanitaria La FeRecruitingEndometrial CancerSpain
-
Gaziosmanpasa Research and Education HospitalRecruiting
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
University of PennsylvaniaEnrolling by invitationMayer Rokitansky Kuster Hauser Syndrome | Uterine Factor Infertility | Uterine Agenesis | Infertility, Female, of Uterine OriginUnited States
-
American University of Beirut Medical CenterCompletedPostpartum HemorrhageLebanon
-
University Hospital, GenevaRecruiting